# ACP3

## Overview
The ACP3 gene encodes the enzyme prostatic acid phosphatase (PAcP), a histidine-dependent phosphatase primarily expressed in the prostate gland. This enzyme plays a pivotal role in phosphate metabolism and cell signaling by catalyzing the hydrolysis of phosphate esters. PAcP exists in both cellular and secretory forms, with the cellular variant acting as a tumor suppressor by regulating tyrosine phosphorylation levels, thereby inhibiting pathways that promote cell proliferation and tumorigenicity (Muniyan2014Cellular). Structurally, PAcP is a homodimeric protein with significant glycosylation and disulfide bonding, essential for its catalytic function (Muniyan2013Human; Hassan2010Structural). The enzyme's activity is crucial for maintaining prostate cell homeostasis and is associated with decreased cell growth, underscoring its importance in prostate health (Muniyan2014Cellular).

## Structure
The human prostatic acid phosphatase (hPAcP), encoded by the ACP3 gene, is initially synthesized as a precursor protein of 386 amino acids. After cleavage of a 32 amino acid signal peptide, the mature protein consists of 354 amino acids with a molecular weight of approximately 41,126 Da (Muniyan2013Human; Hassan2010Structural). The protein is a homodimer, with each subunit containing three N-linked glycosylation sites at Asn62, Asn188, and Asn301, and six cysteine residues forming two disulfide bonds (Cys129-340 and Cys314-319) (Muniyan2013Human; Hassan2010Structural).

The secondary structure of hPAcP is composed of 44% α-helix and 12% β-strand, with the remainder being loops and β-turns (Muniyan2013Human). The tertiary structure reveals two domains per subunit: a larger α/β type domain with a central seven-stranded mixed β-sheet flanked by helices, and a smaller domain with six α-helices (Jakob2000Crystal; Muniyan2013Human). The active site, located between these domains, includes key residues His12 and Asp258, which are crucial for the enzyme's catalytic activity (Muniyan2013Human; Hassan2010Structural).

Dimerization is essential for the enzyme's catalytic function, as it induces structural changes that affect the active site (Jakob2000Crystal). The protein's structure is similar to other histidine phosphatases, with conserved catalytic residues (Jakob2000Crystal).

## Function
The ACP3 gene encodes prostatic acid phosphatase (PAcP), an enzyme primarily active in the prostate gland. PAcP functions as a histidine-dependent phosphatase, catalyzing the hydrolysis of phosphate esters. It plays a crucial role in regulating phosphate metabolism and cell signaling pathways. In healthy prostate cells, PAcP is involved in dephosphorylating tyrosyl phosphorylated proteins, such as the human epidermal growth factor receptor-2 (HER-2/ErbB-2), which is important for controlling cell growth and proliferation (Muniyan2014Cellular; Muniyan2013Human).

PAcP exists in multiple forms, including cellular (cPAcP) and secretory (sPAcP) variants. The cellular form acts as a tumor suppressor by maintaining low levels of tyrosine phosphorylation, thereby inhibiting pathways that lead to increased cell proliferation and tumorigenicity (Muniyan2014Cellular). This enzyme is also involved in the regulation of androgen-stimulated proliferation in prostate cells, contributing to the maintenance of prostate cell homeostasis (Muniyan2013Human).

PAcP is localized in the glandular and ductal regions of the prostate and is highly expressed in differentiated prostate epithelial cells. Its activity is crucial for normal prostate function and is associated with decreased cell growth, highlighting its role in maintaining prostate health (Muniyan2014Cellular).

## Clinical Significance
Mutations and alterations in the expression of the ACP3 gene, also known as prostatic acid phosphatase (PAP), have significant clinical implications. ACP3 is primarily expressed in the prostate and plays a role in dephosphorylation processes. Changes in its expression or mutations are notably associated with prostate cancer, where ACP3 can serve as a biomarker for both diagnosis and prognosis. Elevated levels of ACP3 are often observed in prostate cancer patients, indicating its potential utility in monitoring disease progression and response to treatment.

Beyond prostate cancer, increased ACP3 levels have been linked to other medical conditions. For instance, elevated ACP3 is associated with osteoporosis, suggesting a possible role in bone metabolism and turnover. Additionally, certain inflammatory diseases have been connected to changes in ACP3 expression, although the exact mechanisms and implications of these associations require further investigation. These findings highlight the importance of ACP3 not only in prostate health but also in broader physiological and pathological contexts, making it a target of interest for ongoing research in various disease states.

## Interactions



## References


[1. (Jakob2000Crystal) Clarissa G. Jakob, Krzysztof Lewinski, Radoslawa Kuciel, Wlodzimierz Ostrowski, and Lukasz Lebioda. Crystal structure of human prostatic acid phosphatase. The Prostate, 42(3):211–218, February 2000. URL: http://dx.doi.org/10.1002/(SICI)1097-0045(20000215)42:3<211::AID-PROS7>3.0.CO;2-U, doi:10.1002/(sici)1097-0045(20000215)42:3<211::aid-pros7>3.0.co;2-u. This article has 87 citations.](https://doi.org/10.1002/(SICI)1097-0045(20000215)42:3)

[2. (Muniyan2014Cellular) Sakthivel Muniyan, Matthew A. Ingersoll, Surinder K. Batra, and Ming-Fong Lin. Cellular prostatic acid phosphatase, a pten-functional homologue in prostate epithelia, functions as a prostate-specific tumor suppressor. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1846(1):88–98, August 2014. URL: http://dx.doi.org/10.1016/j.bbcan.2014.04.006, doi:10.1016/j.bbcan.2014.04.006. This article has 10 citations.](https://doi.org/10.1016/j.bbcan.2014.04.006)

[3. (Muniyan2013Human) Sakthivel Muniyan, Yu-Wei Chou, Shou-Qiang Ou-Yang, and Ming-Fong Lin. Human Prostatic Acid Phosphatase in Prostate Carcinogenesis, pages 323–348. Springer New York, 2013. URL: http://dx.doi.org/10.1007/978-1-4614-6828-8_12, doi:10.1007/978-1-4614-6828-8_12. This article has 0 citations.](https://doi.org/10.1007/978-1-4614-6828-8_12)

[4. (Hassan2010Structural) Md Imtaiyaz Hassan, Afnan Aijaz, and Faizan Ahmad. Structural and functional analysis of human prostatic acid phosphatase. Expert Review of Anticancer Therapy, 10(7):1055–1068, July 2010. URL: http://dx.doi.org/10.1586/era.10.46, doi:10.1586/era.10.46. This article has 41 citations and is from a peer-reviewed journal.](https://doi.org/10.1586/era.10.46)